Eintrag weiter verarbeiten
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing brea...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical oncology 32(2014), 29, Seite 3212-3222 |
|---|---|
| Personen und Körperschaften: | , , |
| Titel: | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer/ Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert |
| Format: | E-Book-Kapitel |
| Sprache: | Englisch |
| veröffentlicht: |
8 September 2014
|
| Gesamtaufnahme: |
: Journal of clinical oncology, 32(2014), 29, Seite 3212-3222
, volume:32 |
| Quelle: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
| LEADER | 02602caa a2200541 4500 | ||
|---|---|---|---|
| 001 | 0-1525549294 | ||
| 003 | DE-627 | ||
| 005 | 20220812155058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 160217s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1200/JCO.2014.55.7876 |2 doi | |
| 035 | |a (DE-627)1525549294 | ||
| 035 | |a (DE-576)45554929X | ||
| 035 | |a (DE-599)BSZ45554929X | ||
| 035 | |a (OCoLC)1340900216 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Loibl, Sibylle |e VerfasserIn |0 (DE-588)12433024X |0 (DE-627)085790508 |0 (DE-576)294122753 |4 aut | |
| 245 | 1 | 0 | |a PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |c Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert |
| 264 | 1 | |c 8 September 2014 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am16.02.2016 | ||
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Sinn, Peter |d 1957- |e VerfasserIn |0 (DE-588)1022590944 |0 (DE-627)717004783 |0 (DE-576)365646342 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical oncology |d Alexandria, Va. : American Society of Clinical Oncology, 1983 |g 32(2014), 29, Seite 3212-3222 |h Online-Ressource |w (DE-627)313116962 |w (DE-600)2005181-5 |w (DE-576)090887018 |x 1527-7755 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2014 |g number:29 |g pages:3212-3222 |g extent:11 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2014.55.7876 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 936 | u | w | |d 32 |j 2014 |e 29 |h 3212-3222 |g 11 |
| 951 | |a AR | ||
| 856 | 4 | 0 | |u http://dx.doi.org/10.1200/JCO.2014.55.7876 |9 LFER |
| 852 | |a LFER |z 2016-03-10T00:00:00Z | ||
| 970 | |c OD | ||
| 971 | |c EBOOK | ||
| 972 | |c EBOOK | ||
| 973 | |c Aufsatz | ||
| 935 | |a lfer | ||
| 900 | |a Sinn, Hans Peter | ||
| 900 | |a Sinn, Hans P. | ||
| 900 | |a Sinn, Hans-Peter | ||
| 900 | |a Sinn, H. P. | ||
| 900 | |a Sinn, P. | ||
| 900 | |a Schneeweiß, Andreas | ||
| 900 | |a Schneeweiss, A. | ||
| 951 | |b XA-DE | ||
| 980 | |a 1525549294 |b 0 |k 1525549294 |o 45554929X |c lfer | ||
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=PIK3CA+mutations+are+associated+with+lower+rates+of+pathologic+complete+response+to+anti-human+epidermal+growth+factor+receptor+2+%28HER2%29+therapy+in+primary+HER2-overexpressing+breast+cancer&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Loibl%2C+Sibylle&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1527-7755 |
|---|
| _version_ | 1757947236235345920 |
|---|---|
| access_facet | Electronic Resources |
| author | Loibl, Sibylle, Schneeweiss, Andreas, Sinn, Peter |
| author_facet | Loibl, Sibylle, Schneeweiss, Andreas, Sinn, Peter |
| author_role | aut, aut, aut |
| author_sort | Loibl, Sibylle |
| author_variant | s l sl, a s as, p s ps |
| callnumber-sort | |
| collection | lfer |
| container_reference | 32(2014), 29, Seite 3212-3222 |
| container_title | Journal of clinical oncology |
| ctrlnum | (DE-627)1525549294, (DE-576)45554929X, (DE-599)BSZ45554929X, (OCoLC)1340900216 |
| doi_str_mv | 10.1200/JCO.2014.55.7876 |
| facet_avail | Online, Free |
| finc_class_facet | not assigned |
| finc_id_str | 0017884493 |
| footnote | Gesehen am16.02.2016 |
| format | ElectronicBookComponentPart |
| format_access_txtF_mv | Article, E-Article |
| format_de105 | Ebook |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_del152 | Buch |
| format_detail_txtF_mv | text-online-monograph-child |
| format_dezi4 | e-Book |
| format_finc | Article, E-Article |
| format_legacy | ElectronicBookPart |
| format_strict_txtF_mv | E-Article |
| geogr_code | not assigned |
| geogr_code_person | Germany |
| hierarchy_parent_id | 0-313116962 |
| hierarchy_parent_title | Journal of clinical oncology |
| hierarchy_sequence | 32(2014), 29, Seite 3212-3222 |
| hierarchy_top_id | 0-313116962 |
| hierarchy_top_title | Journal of clinical oncology |
| id | 0-1525549294 |
| illustrated | Not Illustrated |
| imprint | 8 September 2014 |
| imprint_str_mv | 8 September 2014 |
| institution | DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2 |
| is_hierarchy_id | 0-1525549294 |
| is_hierarchy_title | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |
| isil_str_mv | LFER |
| issn | 1527-7755 |
| kxp_id_str | 1525549294 |
| language | English |
| last_indexed | 2023-02-16T00:58:47.557Z |
| marc024a_ct_mv | 10.1200/JCO.2014.55.7876 |
| match_str | loibl2014pik3camutationsareassociatedwithlowerratesofpathologiccompleteresponsetoantihumanepidermalgrowthfactorreceptor2her2therapyinprimaryher2overexpressingbreastcancer |
| mega_collection | Verbunddaten SWB, Lizenzfreie Online-Ressourcen |
| misc_de105 | EBOOK |
| multipart_link | 090887018 |
| multipart_part | (090887018)32(2014), 29, Seite 3212-3222 |
| names_id_str_mv | (DE-588)12433024X, (DE-627)085790508, (DE-576)294122753, (DE-588)109972554, (DE-627)632849630, (DE-576)327251859, (DE-588)1022590944, (DE-627)717004783, (DE-576)365646342 |
| oclc_num | 1340900216 |
| physical | 11 |
| publishDate | 8 September 2014 |
| publishDateSort | 2014 |
| publishPlace | |
| publisher | |
| record_format | marcfinc |
| record_id | 45554929X |
| recordtype | marcfinc |
| rvk_facet | No subject assigned |
| source_id | 0 |
| spelling | Loibl, Sibylle VerfasserIn (DE-588)12433024X (DE-627)085790508 (DE-576)294122753 aut, PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert, 8 September 2014, 11, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am16.02.2016, Schneeweiss, Andreas 1961- VerfasserIn (DE-588)109972554 (DE-627)632849630 (DE-576)327251859 aut, Sinn, Peter 1957- VerfasserIn (DE-588)1022590944 (DE-627)717004783 (DE-576)365646342 aut, Enthalten in Journal of clinical oncology Alexandria, Va. : American Society of Clinical Oncology, 1983 32(2014), 29, Seite 3212-3222 Online-Ressource (DE-627)313116962 (DE-600)2005181-5 (DE-576)090887018 1527-7755 nnns, volume:32 year:2014 number:29 pages:3212-3222 extent:11, http://dx.doi.org/10.1200/JCO.2014.55.7876 Verlag Resolving-System kostenfrei Volltext, http://dx.doi.org/10.1200/JCO.2014.55.7876 LFER, LFER 2016-03-10T00:00:00Z |
| spellingShingle | Loibl, Sibylle, Schneeweiss, Andreas, Sinn, Peter, PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |
| swb_id_str | 45554929X |
| title | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |
| title_auth | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |
| title_full | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert |
| title_fullStr | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert |
| title_full_unstemmed | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert |
| title_in_hierarchy | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer / Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Paepke, Annika Lehmann, Mahdi Rezai,Dirk M. Zahm, Peter Sinn, Fariba Khandan, Holger Eidtmann, Karel Dohnal, Clemens Heinrichs, Jens Huober, Berit Pfitzner, Peter A. Fasching, Fabrice Andre, Judith L. Lindner, Christos Sotiriou, August Dykgers, Sanxing Guo, Stephan Gade, Valentina Nekljudova, Sherene Loi, Michael Untch, and Carsten Denkert, |
| title_short | PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (HER2) therapy in primary HER2-overexpressing breast cancer |
| title_sort | pik3ca mutations are associated with lower rates of pathologic complete response to anti human epidermal growth factor receptor 2 her2 therapy in primary her2 overexpressing breast cancer |
| url | http://dx.doi.org/10.1200/JCO.2014.55.7876 |